Zeitschriftenartikel zum Thema „Inc National Cargo Bureau“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Inc National Cargo Bureau" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Lebwohl, M., A. Deodhar, S. Schwartzman, C. Salvarani, M. Feely, D. Zhu, P. Rahman et al. „AB1105 LONG-TERM SAFETY OF IXEKIZUMAB TREATMENT IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF END-OF-STUDY PROGRAM DATA RELATING TO MAJOR ADVERSE CARDIOVASCULAR EVENTS“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 1780–81. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3412.
Der volle Inhalt der QuelleMatsui, T., N. Sugiyama, S. Toyoizumi, F. Matsuyama, T. Murata, Y. Urata, K. Kawahata und S. Tohma. „POS0286 INCIDENCE OF MALIGNANCIES IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM A LARGE JAPANESE NATIONAL REGISTRY“. Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 368–69. http://dx.doi.org/10.1136/annrheumdis-2021-eular.365.
Der volle Inhalt der QuelleBishop, Ryan T., Tao Li, Raghunandan R. Alugubelli, Oliver Hampton, Ariosto Siqueira Silva, Steven Grant, Kenneth H. Shain und Conor C. Lynch. „Acid Ceramidase (ASAH1) Mediates Intrinsic and Intercellular Transfer of Proteasome Inhibitor Resistance in Multiple Myeloma“. Blood 138, Supplement 1 (05.11.2021): 1206. http://dx.doi.org/10.1182/blood-2021-152686.
Der volle Inhalt der QuelleKhuat, Lam T., Catherine T. Le, Chien-Chun Pai, Robin Shields-Cutler, Shernan Holtan, Armin Rashidi, Sarah Parker et al. „Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation“. Blood 134, Supplement_1 (13.11.2019): 1922. http://dx.doi.org/10.1182/blood-2019-127743.
Der volle Inhalt der QuelleYijun, Liao, Li Ping und Huang Wenjing. „Research on the Impact of GNI on Express Delivery Volume in China“. Journal of Economics and Public Finance 6, Nr. 3 (12.08.2020): p110. http://dx.doi.org/10.22158/jepf.v6n3p110.
Der volle Inhalt der QuelleNakazaki, Kumi, Toshiaki Takezaki, Yosuke Masamoto, Yasushi Miyazaki, Kinuko Mitani und Mineo Kurokawa. „A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan“. Blood 138, Supplement 1 (05.11.2021): 4662. http://dx.doi.org/10.1182/blood-2021-146093.
Der volle Inhalt der QuelleDiugwu, Ikechukwu A., Obioma R. Nwaogbe, Victor Omoke, Solomon T. Johnson und Ashem E. Egila. „Assessment of operational performance of public sector funded infrastructure in Nigeria: the airports perspective“. Independent Journal of Management & Production 10, Nr. 1 (01.02.2019): 133. http://dx.doi.org/10.14807/ijmp.v10i1.828.
Der volle Inhalt der QuelleOjutalayo, John Folayan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu, Akujuobi Aghaegbulam Bonaventure Chidiebere und Theophilus Chinonyerem Nwokedi. „Poverty, Youth Unemployment, Maritime Piracy, and Sea Robbery in Nigeria between 1995 and 2013: A Relationship Assessment“. Maritime Technology and Research 5, Nr. 4 (13.07.2023): 265349. http://dx.doi.org/10.33175/mtr.2023.265349.
Der volle Inhalt der QuelleRubnitz, Jeffrey E., Thomas B. Alexander, Theodore W. Laetsch, Seong Lin Khaw, Vinod A. Pullarkat, Joseph T. Opferman, Kathryn G. Roberts et al. „Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma“. Blood 136, Supplement 1 (05.11.2020): 12–13. http://dx.doi.org/10.1182/blood-2020-134582.
Der volle Inhalt der QuelleCasulo, Carla, Michelle Byrtek, Keith L. Dawson, Xiaolei Zhou, Christopher R. Flowers, Charles M. Farber, John D. Hainsworth, James R. Cerhan, Brian K. Link und Jonathan W. Friedberg. „Disease Characteristics, Treatment Patterns, and Outcomes of Follicular Lymphoma in Patients 40 Years of Age and Younger: An Analysis from the National LymphoCare Study“. Blood 124, Nr. 21 (06.12.2014): 3044. http://dx.doi.org/10.1182/blood.v124.21.3044.3044.
Der volle Inhalt der QuelleLee, Seung Tae, Antonio Pinto, Habte Yimer, Don Stevens, Wanda Knopinska Posluszny, Merrill Kingman Shum, Sudhir Manda et al. „A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)“. Blood 138, Supplement 1 (05.11.2021): 1420. http://dx.doi.org/10.1182/blood-2021-150025.
Der volle Inhalt der QuelleJourneycake, Janna M., Cedric Hermans, Jonathan M. Ducore, Miguel A. Escobar, Guy Young, Michael Wang, Doris Quon et al. „Single 225μg/Kg Dose Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Rapid Hemostasis in Joint Bleeds for Persons with Hemophilia Α or Β with Inhibitors: A PERSEPT1 Subset Analysis“. Blood 136, Supplement 1 (05.11.2020): 2–3. http://dx.doi.org/10.1182/blood-2020-136443.
Der volle Inhalt der QuelleConnelly, K., R. Kandane-Rathnayake, V. Golder, W. Louthrenoo, Y. H. Chen, J. Cho, A. Lateef et al. „POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 1095.2–1096. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2885.
Der volle Inhalt der QuelleSavage, Kerry J., Steven M. Horwitz, Ranjana H. Advani, Jacob H. Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser et al. „An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant“. Blood 134, Supplement_1 (13.11.2019): 464. http://dx.doi.org/10.1182/blood-2019-122781.
Der volle Inhalt der QuelleZinzani, Pier Luigi, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A. Reeves, Wanda Knopinska-Posluszny et al. „Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial“. Blood 136, Supplement 1 (05.11.2020): 34–35. http://dx.doi.org/10.1182/blood-2020-134851.
Der volle Inhalt der QuellePipe, Steven W., Michael Recht, Nigel S. Key, Frank W. G. Leebeek, Giancarlo Castaman, Susan U. Lattimore, Paul Van Der Valk et al. „First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies“. Blood 136, Supplement_2 (19.11.2020): LBA—6—LBA—6. http://dx.doi.org/10.1182/blood-2020-143560.
Der volle Inhalt der QuelleKwak, Larry W., Juan Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim et al. „Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma“. Blood 136, Supplement 1 (05.11.2020): 27–28. http://dx.doi.org/10.1182/blood-2020-135999.
Der volle Inhalt der QuelleEscobar, Miguel A., Doris Quon, Cindy A. Leissinger, James V. Luck, Ahmad Al-Sabbagh, Daniel Bonzo, Ian S. Mitchell, W. Allan Alexander und Cedric Hermans. „PERSEPT3: A Phase 3 Clinical Trial to Evaluate the Hemostatic Efficacy of Eptacog Beta (Recombinant Human FVIIa) in Perioperative Care in Subjects with Hemophilia Α or B with Inhibitors“. Blood 136, Supplement 1 (05.11.2020): 34–36. http://dx.doi.org/10.1182/blood-2020-136448.
Der volle Inhalt der QuelleMatsuda, Kensuke, Taisuke Jo, Masashi Miyauchi, Kazuhiro Toyama, Kumi Nakazaki, Hideo Yasunaga und Mineo Kurokawa. „Primary Prophylaxis with Pegfilgrastim in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Nation-Wide, Propensity Score Based Analysis“. Blood 134, Supplement_1 (13.11.2019): 1605. http://dx.doi.org/10.1182/blood-2019-123611.
Der volle Inhalt der QuelleLee, Hun Ju, Michael Choi, Tanya Siddiqi, Jacqueline Barrientos, William G. Wierda, Iris Isufi, Joseph Tuscano et al. „Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)“. Blood 138, Supplement 1 (05.11.2021): 3534. http://dx.doi.org/10.1182/blood-2021-148779.
Der volle Inhalt der QuelleMcGraw, Kathy L., Chia-Ho Cheng, Y. Ann Chen, Hsin-An Hou, Guilio Genovese, Thomas Cluzeau, Andrea Pellagatti et al. „SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition“. Blood 132, Supplement 1 (29.11.2018): 107. http://dx.doi.org/10.1182/blood-2018-99-118747.
Der volle Inhalt der QuelleWolach, Ofir, Itai Levi, Jonathan Canaani, Tamar Tadmor, Sigal Tavor, Ilana Hellmann, Tsila Zuckerman et al. „First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study“. Blood 136, Supplement 1 (05.11.2020): 27–28. http://dx.doi.org/10.1182/blood-2020-139923.
Der volle Inhalt der QuelleKernder, A., H. Morf, P. Klemm, D. Vossen, M. Meyer, I. Haase, J. Mucke et al. „POS1458-HPR DIGITAL RHEUMATOLOGY IN THE ERA OF COVID-19: RESULTS OF A NATIONAL PATIENT AND PHYSICIAN SURVEY“. Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 1013–14. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1328.
Der volle Inhalt der QuelleGhia, Paolo, John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Bryone J. Kuss, Stephen Opat, Ian W. Flinn et al. „First-Line Treatment with Ibrutinib (Ibr) Plus Venetoclax (Ven) for Chronic Lymphocytic Leukemia (CLL): 2-Year Post-Randomization Disease-Free Survival (DFS) Results from the Minimal Residual Disease (MRD) Cohort of the Phase 2 Captivate Study“. Blood 138, Supplement 1 (05.11.2021): 68. http://dx.doi.org/10.1182/blood-2021-144544.
Der volle Inhalt der QuelleGribben, John G., Wojciech Jurczak, Ryan W. Jacobs, Sebastian Grosicki, Krzysztof Giannopoulos, Tomasz Wrobel, Syed F. Zafar et al. „Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study“. Blood 136, Supplement 1 (05.11.2020): 37–39. http://dx.doi.org/10.1182/blood-2020-134783.
Der volle Inhalt der QuelleSchiller, Gary J., Laura Finn, Gail J. Roboz, Johnnie J. Orozco, Tiffany Lin, Mary M. Chen und Mohamed M. Hegazi. „Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML“. Blood 138, Supplement 1 (05.11.2021): 3412. http://dx.doi.org/10.1182/blood-2021-146018.
Der volle Inhalt der QuelleCostello, Caitlin L., Tara K. Gregory, Syed Abbas Ali, Jesus G. Berdeja, Krina K. Patel, Nina D. Shah, Eric Ostertag et al. „Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)“. Blood 134, Supplement_1 (13.11.2019): 3184. http://dx.doi.org/10.1182/blood-2019-129562.
Der volle Inhalt der QuelleRollison, Dana E., Kenneth H. Shain, Ji-Hyun Lee, Shalaka S. Hampras, William Fulp, Kate Fisher, Najla H. Al Ali et al. „Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients“. Blood 124, Nr. 21 (06.12.2014): 1912. http://dx.doi.org/10.1182/blood.v124.21.1912.1912.
Der volle Inhalt der QuelleContributors. „ACKNOWLEDGMENTS“. Acta Medica Philippina 54, Nr. 6 (26.12.2020). http://dx.doi.org/10.47895/amp.v54i6.2626.
Der volle Inhalt der QuelleKANIA, MICHAL, BEATA KON, KONRAD M. KAMINSKI, JERZY HOHENDORFF, TOMASZ KLUPA, PRZEMYSLAW W. WITEK und MACIEJ MALECKI. „1841-PUB: Diabetes as a Risk Factor of Death in Hospitalized COVID-19 Patients—An Analysis of a National Hospitalization Database from Poland, 2020“. Diabetes 72, Supplement_1 (23.06.2023). http://dx.doi.org/10.2337/db23-1841-pub.
Der volle Inhalt der QuelleLEELARATHNA, LALANTHA, CHRIS J. SUTTON, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON et al. „951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study“. Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-951-p.
Der volle Inhalt der QuelleFORLENZA, GREGORY P., SARAH A. MACLEISH, DOROTHY I. SHULMAN, BENJAMIN U. NWOSU, SIHAM ACCACHA, SATISH K. GARG, ANDERS L. CARLSON et al. „1901-LB: Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1901-lb.
Der volle Inhalt der QuelleMAGLIANO, DIANNA J., LEI CHEN, JEDIDIAH I. MORTON, AGUS SALIM, BENDIX CARSTENSEN, EDWARD W. GREGG, MEDA E. PAVKOV et al. „1380-P: A Multicountry Analysis of Trends in Incidence of Young-Onset Type 2 Diabetes“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1380-p.
Der volle Inhalt der QuelleCHEPP, VALERIE, STEVEN P. MASIANO, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE und ANITA D. MISRA-HEBERT. „1125-P: Provider Experience Caring for Elderly Patients with Uncontrolled Type 2 Diabetes and Hospitalization“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1125-p.
Der volle Inhalt der QuelleOjutalayo, John Folamyan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu und Theophilus Chinonyerem Nwokedi. „Study on the Effects of Maritime Piracy and Sea Robbery on Economic Growth in Nigeria“. International Journal of Social Science and Research 1, Nr. 1 (06.09.2023). http://dx.doi.org/10.58531/ijssr/1/1/2.
Der volle Inhalt der QuelleVIGERSKY, ROBERT A., BRUCE W. BODE, RONALD L. BRAZG, BRUCE A. BUCKINGHAM, ANDERS L. CARLSON, KEVIN B. KAISERMAN, MARK KIPNES et al. „100-LB: Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) —Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results“. Diabetes 71, Supplement_1 (01.06.2022). http://dx.doi.org/10.2337/db22-100-lb.
Der volle Inhalt der QuelleBARNARD, KATHARINE, VICKY P. TAXIARCHI, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON et al. „633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study“. Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-633-p.
Der volle Inhalt der QuelleMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. „1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1895-lb.
Der volle Inhalt der QuelleMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. „1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1896-lb.
Der volle Inhalt der QuelleWEINSTOCK, RUTH S., ZACHARY THOMPSON, RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER et al. „263-OR: Older Adults Benefit from Virtual Support for CGM Use but Require Longer Visits“. Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-263-or.
Der volle Inhalt der QuelleMASIANO, STEVEN P., LARISA G. TERESHCHENKO, VALERIE CHEPP, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE und ANITA D. MISRA-HEBERT. „1111-P: Predictors of Type 2 Diabetes (T2D) Medication Change and Improved A1C among Older Adults Post-hospitalization“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-1111-p.
Der volle Inhalt der QuelleMILLER, KELLEE, HUYEN NGUYEN, JENNIFER L. SHERR, YOGISH C. KUDVA, ANDERS L. CARLSON, NAOMI CHAYTOR, DANIEL DESALVO et al. „265-OR: Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes—A T1D Exchange (T1DX) Online Registry Analysis“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-265-or.
Der volle Inhalt der QuelleBODE, BRUCE W., TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN, SATISH K. GARG, KEVIN B. KAISERMAN, DAVID R. LILJENQUIST et al. „672-P: Performance of a New Disposable Zero-Calibration Continuous Glucose Monitoring (CGM) Sensor“. Diabetes 71, Supplement_1 (01.06.2022). http://dx.doi.org/10.2337/db22-672-p.
Der volle Inhalt der QuelleFAULDS, EILEEN R., YASAMAN BADAKHSHI, ANDREW BOUTSICARIS, MATTHEW C. EXLINE, JOI HESTER, LAUREEN G. JONES, MOLLY MCNETT et al. „230-OR: Hybrid Continuous Glucose Monitoring Protocols in the Intensive Care Unit—Multicenter Experience“. Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-230-or.
Der volle Inhalt der QuelleEBERT, THOMAS, NOSHEEN SATTAR, MARNI GREIG, CLAUDIA LAMINA, MARC FROISSART, KAI-UWE ECKARDT, JÜRGEN FLOEGE et al. „808-P: Association between Analogue Compared with Human Insulin and the Outcomes of Mortality, Hospitalization, MACE, and Hypoglycemia in Hemodialysis Patients with Type 2 Diabetes: The ARO Research Initiative“. Diabetes 71, Supplement_1 (01.06.2022). http://dx.doi.org/10.2337/db22-808-p.
Der volle Inhalt der QuelleDUBSKY, MICHAL, ROBERT ROLAND, NATÁLIA MARHEFKOVÁ, PETER WOHLFAHRT, PETER NOVODVORSKY, VLADIMIR KARMAZIN, MARTIN HALUZIK und MICHAL PAZDERNIK. „185-OR: The Role of Optical Coherent Tomography in the Estimation of Cardiovascular Risk in Asymptomatic Patients with Type 1 Diabetes“. Diabetes 73, Supplement_1 (14.06.2024). http://dx.doi.org/10.2337/db24-185-or.
Der volle Inhalt der QuelleDESHMUKH, HARSHAL, BEATRICE PIERI, EMMA G. WILMOT, PRATIK CHOUDHARY, NAJEEB SHAH, VASILEIOS TSATLIDIS, ALISTAIR N. LUMB, ROBERT E. RYDER, CHRISTOPHER WALTON und THOZHUKAT SATHYAPALAN. „90-OR: FreeStyle Libre (FSL) Time in Range (TIR) and Time Below Range (TBR) : Impact on HbA1c, Diabetes-Related Distress (DRD) , and Resource Utilisation in the Association of British Clinical Diabetologists (ABCD) National Audit“. Diabetes 71, Supplement_1 (01.06.2022). http://dx.doi.org/10.2337/db22-90-or.
Der volle Inhalt der QuelleFORLENZA, GREGORY P., BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, SUE A. BROWN, RUTH S. WEINSTOCK, DAVID W. HANSEN et al. „766-P: Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years“. Diabetes 71, Supplement_1 (01.06.2022). http://dx.doi.org/10.2337/db22-766-p.
Der volle Inhalt der QuelleSCHOELWER, MELISSA, BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, GREGORY P. FORLENZA, RUTH S. WEINSTOCK, DAVID W. HANSEN et al. „765-P: Glycemic Outcomes across Total Daily Insulin Doses with the Omnipod 5 Automated Insulin Delivery System (AID) among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years“. Diabetes 71, Supplement_1 (01.06.2022). http://dx.doi.org/10.2337/db22-765-p.
Der volle Inhalt der QuelleHOOD, KOREY K., RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER, MARY L. JOHNSON et al. „1031-P: Virtual Clinic Support—Patient-Reported Outcome Benefits“. Diabetes 72, Supplement_1 (20.06.2023). http://dx.doi.org/10.2337/db23-1031-p.
Der volle Inhalt der Quelle